Gut bacteria make stroke damage worse

After a stroke, the immune system becomes dysregulated. Brain inflammation escalates, damaging more tissue than the stroke itself. Researchers wanted to understand why some people suffer such severe immune reactions. Part of the answer lies in the gut.

Certain gut bacteria, including a common strain of Escherichia coli, convert the amino acid tryptophan into indole. This metabolite is normally present in small amounts in the blood. The researchers, publishing in the journal Cell, showed that indole is associated with worse outcomes after ischemic stroke in both mice and patients.

A receptor as a switch

Indole binds to a receptor on certain immune cells called dendritic cells, known as the aryl hydrocarbon receptor (AHR). Through this receptor, indole pushes dendritic cells toward a profile that amplifies brain inflammation. At the same time, regulatory T cells (Tregs) become less active, releasing the brake on inflammation.

The researchers blocked this receptor in mice, both genetically and pharmacologically. Mice with a blocked receptor showed less brain inflammation and better stroke outcomes. When Tregs were artificially depleted, the protective effect disappeared. This suggests Tregs are central to recovery.

One point in a chain

What makes this research relevant for longevity is how concretely it maps the microbiome-immune-brain axis. Older people more often have disrupted gut flora and a higher stroke risk. If gut metabolism partly determines the severity of stroke damage, the microbiome becomes a potential target for recovery treatment.

The findings are preliminary. Most experiments were conducted in mice, though the results correlate with patient data as well. Whether AHR inhibition is safe and effective in humans remains to be established. But the principle, that a single bacterial metabolite triggers a cascade of immune events that damages the brain, offers a concrete new therapeutic target.

Read the original article